These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6141881)

  • 1. DOPA decarboxylase activity in the nervous system and the ctenidium of the freshwater clam, Musculium (Sphaerium) transversum.
    Paparo AA; Murphy JA; Dean RC
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1984; 77(1):55-7. PubMed ID: 6141881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopa decarboxylase from visceral ganglion and gill of two lamellibranch mollusca as it relates to ciliary activity.
    Paparo AA; Tate SS
    Comp Gen Pharmacol; 1973 Dec; 4(16):383-91. PubMed ID: 4788788
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of decarboxylase and levels of dopa and 3-O-methyldopa: a comparative study of benserazide versus carbidopa in rodents and of Madopar standard versus Madopar HBS in volunteers.
    Da Prada M; Kettler R; Zürcher G; Schaffner R; Haefely WE
    Eur Neurol; 1987; 27 Suppl 1():9-20. PubMed ID: 3123242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of VB6 on L-DOPA decarboxylase activity in the organs of rats given peripheral L-DOPA decarboxylase inhibitors (author's transl)].
    Yoshimine N; Kuzuya F; Mori K; Sakamoto N
    Nihon Ronen Igakkai Zasshi; 1978 Nov; 15(6):566-73. PubMed ID: 732010
    [No Abstract]   [Full Text] [Related]  

  • 5. A kinetic analysis of Drosophila melanogaster dopa decarboxylase.
    Black BC; Smarrelli J
    Biochim Biophys Acta; 1986 Mar; 870(1):31-40. PubMed ID: 3081033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The timing of administration, dose dependence and efficacy of dopa decarboxylase inhibitors on the reversal of motor disability produced by L-DOPA in the MPTP-treated common marmoset.
    Tayarani-Binazir KA; Jackson MJ; Fisher R; Zoubiane G; Rose S; Jenner P
    Eur J Pharmacol; 2010 Jun; 635(1-3):109-16. PubMed ID: 20303948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous dopamine synthesis and dopa-decarboxylase activity in rat renal cortex.
    Wahbe F; Hagege J; Loreau N; Ardaillou R
    Mol Cell Endocrinol; 1982 Jun; 27(1):45-54. PubMed ID: 7106369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal dopa decarboxylase.
    Siow YL; Dakshinamurti K
    Ann N Y Acad Sci; 1990; 585():173-88. PubMed ID: 2192610
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of radiolabeled monofluoromethyl-Dopa to define the subunit structure of human L-Dopa decarboxylase.
    Maneckjee R; Baylin SB
    Biochemistry; 1983 Dec; 22(26):6058-63. PubMed ID: 6661425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the effects of decarboxylase inhibitors on L-dopa-induced circling behavior and the conversion of dopa to dopamine in the brain.
    Goodale DB; Moore KE
    Life Sci; 1976 Sep; 19(5):701-6. PubMed ID: 957902
    [No Abstract]   [Full Text] [Related]  

  • 11. Binding site of salsolinol: its properties in different regions of the brain and the pituitary gland of the rat.
    Homicskó KG; Kertész I; Radnai B; Tóth BE; Tóth G; Fülöp F; Fekete MI; Nagy GM
    Neurochem Int; 2003 Jan; 42(1):19-26. PubMed ID: 12441164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The analog inhibitor, alpha-methyl dopa, as a screening agent for mutants elevating levels of dopa decarboxylase activity in Drosophila melanogaster.
    Sherald AF; Wright TR
    Mol Gen Genet; 1974; 133(1):25-36. PubMed ID: 4214992
    [No Abstract]   [Full Text] [Related]  

  • 13. The characterization of histidine decarboxylase and its distribution in nerves, ganglia and in single neuronal cell bodies from the CNS of Aplysia californica.
    Weinreich D; Yu Y-T
    J Neurochem; 1977 Feb; 28(2):361-9. PubMed ID: 839218
    [No Abstract]   [Full Text] [Related]  

  • 14. Benserazide decreases central AADC activity, extracellular dopamine levels and levodopa decarboxylation in striatum of the rat.
    Jonkers N; Sarre S; Ebinger G; Michotte Y
    J Neural Transm (Vienna); 2001; 108(5):559-70. PubMed ID: 11459076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of STH and 6-OH-dopa on the SEM of the branchial nerve and visceral ganglion of the bivalve Elliptio complanata as it relates to ciliary activity.
    Paparo AA; Murphy JA
    Comp Biochem Physiol C Comp Pharmacol; 1975 Aug; 51(2):169-70. PubMed ID: 241576
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of benserazide on L-DOPA-derived extracellular dopamine levels and aromatic L-amino acid decarboxylase activity in the striatum of 6-hydroxydopamine-lesioned rats.
    Shen H; Kannari K; Yamato H; Arai A; Matsunaga M
    Tohoku J Exp Med; 2003 Mar; 199(3):149-59. PubMed ID: 12703659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The selection for mutants in Drosophila melanogaster hypersensitive to alpha-methyl dopa, a dopa decarboxylase inhibitor.
    Sparrow JC; Wright TR
    Mol Gen Genet; 1974 May; 130(2):127-41. PubMed ID: 4209419
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of the inhibition of aromatic aminoacids decarboxylase on prolactin secretion in humans.
    Masturzo P; Murialdo G; Carolei A; Polleri A
    Boll Soc Ital Biol Sper; 1979 Feb; 55(4):366-72. PubMed ID: 552852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some aspects on L-dopa decarboxylase and p-tyrosine decarboxylase in the central nervous and peripheral tissues of the American cockroach Periplaneta americana.
    Yu PH; Sloley BD
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1987; 87(2):315-9. PubMed ID: 2888574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic and in vitro effects of GAD and GABA-T inhibitors on AADC activity and of AADC inhibitors on GAD.
    Giorgi O; Rubio MC
    Gen Pharmacol; 1981; 12(4):217-23. PubMed ID: 7250670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.